Differential regulation of corticotropin-releasing factor(1) receptor expression by stress and agonist treatments in brain and cultured cells

被引:0
|
作者
Iredale, PA
Terwilliger, R
Widnell, KL
Nestler, EJ
Duman, RS
机构
[1] YALE UNIV,SCH MED,CONNECTICUT MENTAL HLTH CTR,DEPT PSYCHIAT,LAB MOL PSYCHIAT,NEW HAVEN,CT 06508
[2] YALE UNIV,SCH MED,CONNECTICUT MENTAL HLTH CTR,DEPT PHARMACOL,NEW HAVEN,CT 06508
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Corticotropin-releasing factor (CRF) is known to play a major role in coordinating neuroendocrine and behavioral responses to stress. We demonstrate that expression of the CRF(1) receptor (CRF-R1) is regulated by stress in the brain and by agonist treatments in cultured cells. Expression of CRF-R1 mRNA was decreased in the frontal cortex but increased in the hippocampus by chronic unpredictable stress. Chronic corticosterone administration did not influence levels of CRF-R1 mRNA in either region, suggesting that regulation of CRF-R1 expression is mediated by CRF itself or by another stress-related factor. Differential regulation of CRF-R1 mRNA by agonist treatment was also observed in two cultured cell lines. In CATH.a cells, a neuron-derived cell line, incubation with CRF decreased levels of CRF-R1 mRNA, whereas in AtT-20 cells, a pituitary-derived cell line, agonist (CRF) treatment increased levels of CRF-R1 mRNA. Further studies demonstrated that the observed changes in both cell lines could be accounted for by regulation of CRF-R1 gene transcription and not by altered mRNA stability. Furthermore, agonist-induced down-regulation of CRF-R1 transcription rate in CATH.a cells was found to be dependent on de novo protein synthesis, suggesting the involvement of an inducible repressor. The results show that different cell types show differential transcriptional regulation of the CRF-R1, which could explain the region-specific regulation of receptor expression in the brain.
引用
收藏
页码:1103 / 1110
页数:8
相关论文
共 50 条
  • [31] Type 1 Corticotropin-Releasing Factor Receptor Expression Reported in BAC Transgenic Mice: Implications for Reconciling Ligand-Receptor Mismatch in the Central Corticotropin-Releasing Factor System
    Justice, Nicholas J.
    Yuan, Zung Fan
    Sawchenko, Paul E.
    Vale, Wylie
    JOURNAL OF COMPARATIVE NEUROLOGY, 2008, 511 (04) : 479 - 496
  • [32] Corticotropin-releasing factor 1 receptor antagonists: a patent review
    Williams, John P.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (08) : 1057 - 1068
  • [33] Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells
    Papadopoulou, NG
    Oleson, L
    Kempuraj, D
    Donelan, J
    Cetrulo, CL
    Theoharides, TC
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2005, 35 (03) : R1 - R8
  • [34] Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart
    Kimura, Y
    Takahashi, K
    Totsune, K
    Muramatsu, Y
    Kaneko, C
    Darnel, AD
    Suzuki, T
    Ebina, M
    Nukiwa, T
    Sasano, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01): : 340 - 346
  • [35] Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa
    Muramatsu, Y
    Fukushima, K
    Iino, K
    Totsune, K
    Takahashi, K
    Suzuki, T
    Hirasawa, G
    Takeyama, J
    Ito, M
    Nose, M
    Tashiro, A
    Hongo, M
    Oki, Y
    Nagura, H
    Sasano, H
    PEPTIDES, 2000, 21 (12) : 1799 - 1809
  • [36] EXPRESSION OF CORTICOTROPIN-RELEASING FACTOR MESSENGER-RNA IN RESPONSE TO STRESS
    LIGHTMAN, SL
    HARBUZ, MS
    CIBA FOUNDATION SYMPOSIA, 1993, 172 : 173 - 198
  • [37] Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model
    Tezval, H
    Jahn, O
    Todorovic, C
    Sasse, A
    Eckart, K
    Spiess, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (25) : 9468 - 9473
  • [38] Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during ''binge''-pattern cocaine administration and chronic withdrawal
    Zhou, Y
    Spangler, R
    LaForge, KS
    Maggos, CE
    Ho, A
    Kreek, MJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 279 (01): : 351 - 358
  • [39] Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor
    Hamke, Maike
    Herpfer, Inga
    Lieb, Klaus
    Wandelt, Carolin
    Fiebich, Bernd L.
    BRAIN RESEARCH, 2006, 1102 : 135 - 144
  • [40] Expression and Regulation of Corticotropin-Releasing Factor Receptor Type 2β in Developing and Mature Mouse Skeletal Muscle
    Kuperman, Yael
    Issler, Orna
    Vaughan, Joan
    Bilezikjian, Louise
    Vale, Wylie
    Chen, Alon
    MOLECULAR ENDOCRINOLOGY, 2011, 25 (01) : 157 - 169